Bacterial ghosts (BGs) represent an innovative platform that exploits empty Gram‐negative bacterial envelopes produced through controlled lysis. These envelopes retain the native antigenic ...

An estimated 475,000 lives were saved in England and Scotland, but the inquiry says a lower vaccine uptake among some groups ...

The mRNA vaccine CDMO market is rapidly expanding, driven by growing biotech startups, limited in-house manufacturing, and ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never ...

Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.

Verndari is one of four companies selected by BARDA to develop alternative vaccine delivery technologies for existing and emerging infectious diseases. Verndari’s VaxiPatch™ technology shows ...

Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...

The coronavirus has ground social, economic, and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of ...

Advancements in next-generation RNA platforms, strategic collaborations, and rising global immunization demand drive a projected CAGR of 10.69% from 2026 to 2035.Austin, United States, April 16, 2026 ...